Relievant Medsystems Patent Covers Vertebral Denervation Device
Summary
The USPTO granted Patent US12605199B2 to Relievant Medsystems, Inc. on April 21, 2026. The patent covers systems and methods for treating back pain associated with a vertebral body using an external energy source configured to deliver therapeutic energy that modulates nerves within or near the vertebral body. The patent includes 20 claims and CPC classifications spanning surgical devices (A61B 18/14), linear drive systems, and therapeutic energy delivery configurations.
What changed
The USPTO granted Patent US12605199B2 to Relievant Medsystems, Inc., covering methods and systems for denervating a vertebral body using an external energy source. The system includes a linear drive for translating the external energy source, a computer coupled to the source for determining target treatment sites based on imaging data, and programming for positioning the focal point and delivering therapeutic energy to modulate nerves. The patent's filing date was May 17, 2024, with Application No. 18667846.
Medical device manufacturers developing spinal pain treatment technologies should review this patent when assessing freedom-to-operate for vertebral denervation systems. Competitors in the intravertebral or spinal pain management device space may need to evaluate licensing opportunities or design-around options to avoid infringement on the 20 claims granted.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Methods of denervating vertebral body using external energy source
Grant US12605199B2 Kind: B2 Apr 21, 2026
Assignee
Relievant Medsystems, Inc.
Inventors
Richard C. Pellegrino, Rex Peters
Abstract
Systems and methods are disclosed for treating back pain associated with a vertebral body of a patient. The system may include an external energy source configured to be positioned at a location external to the body of the patient, a linear configured to drive translation of the external source in one or more axes, a computer coupled to the external source and linear drive and programming executable on said computer for determining a target treatment site within or near the vertebral body based on acquired imaging data, positioning a focal point of the external energy source to substantially coincide with the target treatment site, and delivering a treatment dose of therapeutic energy at said target treatment site, wherein the treatment dose is configured to modulate a nerve within or near the vertebral body.
CPC Classifications
A61B 18/14 A61B 17/025 A61B 18/1815 A61B 2017/0256 A61B 2018/00339 A61B 2018/00577 A61B 2018/00982 A61F 7/00 A61M 5/00 A61N 5/045 A61N 5/10 A61N 5/1049
Filing Date
2024-05-17
Application No.
18667846
Claims
20
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Grants - Diagnosis & Surgery (A61B)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Diagnosis & Surgery (A61B) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.